Skip to Main content Skip to Navigation
Journal articles

Angiomes superficiels : traitements

Abstract : Beta-blockers are efficient for treating complicated infantile hemangiomas; propranolol is currently the first-line treatment. Superficial vascular malformations have to be managed by multidisciplinary teams. T2 FAT-SAT MRI is the most interesting sequence to explore superficial vascular malformations. Recent advances in molecular biology allow exploring new genetic mutations which could be involved in vascular malformations and be the target of new drugs. Mammalian target of rapamycin (mTOR) inhibitors are promising drugs for slow-flow malformations. Arteriovenous malformations are aggressive lesions with very few treatment options.
Document type :
Journal articles
Complete list of metadata

https://hal.inrae.fr/hal-02621772
Contributor : Accord Elsevier CCSD Connect in order to contact the contributor
Submitted on : Monday, October 25, 2021 - 9:51:46 AM
Last modification on : Thursday, April 21, 2022 - 9:34:16 AM
Long-term archiving on: : Wednesday, January 26, 2022 - 6:50:56 PM

File

S0755498219301551.pdf
Files produced by the author(s)

Licence


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Citation

Kevin Janot, Fakhreddine Boustia, Annabel Maruani, Gérard Lorette, Denis Herbreteau. Angiomes superficiels : traitements. La Presse Médicale, Elsevier Masson, 2019, 48 (4), pp.388-397. ⟨10.1016/j.lpm.2019.03.010⟩. ⟨hal-02621772⟩

Share

Metrics

Record views

24

Files downloads

64